US FDA evaluating effectiveness of COVID-19 vaccines against Omicron
BioNTech and Pfizer's established COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant.
Full Article
US FDA evaluating effectiveness of COVID-19 vaccines against Omicron
Jerusalem Post
0 shares
2 views
You might like
Related news coverage
Omicron Variant May Have Reached Europe Earlier Than Thought
Newsy
Watch VideoEconomic powerhouses Japan and France reported their first cases of the omicron variant Tuesday, while new findings..
-
Moderna CEO Sounds Alarm on Reduced Vaccine Effectiveness Against Omicron: ‘This Is Not Going to Be Good’
Mediaite
-
CAC-40 Plunges As Vaccine Efficacy, Economic Data Ruin Sentiment
RTTNews
-
Oil heads for biggest monthly loss since March 2020, after Moderna boss questions vaccine effectiveness against Omicron
Business Insider
-
US stocks bounce back from sell-off as panic over Omicron variant eases
Business Insider
Advertisement
More coverage
The Omicron variant has a 'record' number of mutations that may hinder vaccine effectiveness, NIH director says
Business Insider
"It does make you worry, therefore, that it's a sufficiently different virus, that it might not respond as well to protection from..